Moderna’s vaccine breakthrough reveals the folly of UK efforts
The effect that a commercially-available vaccine would have on the global economy was amply demonstrated on Monday afternoon. The FTSE 100 jumped by more than 4 per cent after an announcement from US drug company Moderna that results of phase one vaccine trials had been successful. Development of a vaccine has become an international race with Moderna, the AstraZeneca-Oxford University project and Chinese work among those in the frame. The government would be advised to stop dangling the elusive possibility of a vaccine arriving by this September Of all of them, Moderna has a headstart. Its trial vaccine, mRNA-1273, was first sequenced on 13 January, just two days after China
